Development of a novel mechanism-based glycolipid adjuvant for vaccination [version 1; referees: 4 approved]
The inability to elicit strong and durable cellular responses is a major obstacle in the development of successful vaccines, in particular those against malaria. In this regard, the generation of novel adjuvants that will potently boost cell-mediated immunity induced by candidate vaccines is helpful...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2018-05-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/7-676/v1 |